Q4 2013 Holdings
Filed 2014-01-28 | 57 holdings | $82.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Idec, Inc.(BIIB) | Common | 09062X103 | $53.7M | 191,983 | 65.3% |
| BioMarin Pharmaceutical Inc.(BMRN) | Common | 09061G101 | $18.1M | 258,241 | 22.1% |
| Accuray, Inc.(ARAY) | Common | 004397105 | $6.4M | 731,943 | 7.8% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | Common | 02043Q107 | $3.1M | 48,695 | 3.8% |
| Gilead Sciences, Inc.(GILD) | Common | 375558103 | $113.1K | 1,504,712 | 0.1% |
| Celgene Corporation(CELG) | Common | 151020104 | $86.2K | 510,046 | 0.1% |
| Regeneron Pharmaceuticals, Inc.(REGN) | Common | 75886F107 | $71.8K | 260,699 | 0.1% |
| Alexion Pharmaceuticals, Inc.(ALXN) | Common | 015351109 | $49.4K | 371,329 | 0.1% |
| Amgen, Inc.(AMGN) | Common | 031162100 | $47.1K | 412,143 | 0.1% |
| Vertex Pharmaceuticals, Inc.(VRTX) | Common | 92532F100 | $37.1K | 499,764 | 0.0% |
| Actavis plc | Shares | G0083B108 | $34.6K | 205,707 | 0.0% |
| Perrigo Company plc(PRGO) | Common | G97822103 | $33.9K | 221,124 | 0.0% |
| Ishares Nasdaq Biotechnology ETF(IBB) | ETF | 464287556 | $30.9K | 136,106 | 0.0% |
| Incyte Corporation(INCY) | Common | 45337C102 | $29.8K | 588,300 | 0.0% |
| Akorn, Inc.(AKRXEUR) | Common | 009728106 | $23.0K | 935,758 | 0.0% |
| Shire plc | Sponsored ADR | 82481R106 | $21.8K | 154,153 | 0.0% |
| Mylan, Inc. | Common | 628530107 | $21.2K | 488,209 | 0.0% |
| Puma Biotechnology, Inc.(PBYI) | Common | 74587V107 | $19.2K | 185,820 | 0.0% |
| Allergan, Inc. | Common | 018490102 | $18.5K | 166,577 | 0.0% |
| Aetna, Inc. | Common | 00817Y108 | $16.9K | 246,841 | 0.0% |
| Cubist Pharmaceuticals, Inc. | Common | 229678107 | $15.6K | 226,772 | 0.0% |
| Alere, Inc. | Common | 01449J105 | $13.4K | 369,553 | 0.0% |
| Teva Pharmaceutical Industries Ltd.(TEVA) | ADR | 881624209 | $12.5K | 311,476 | 0.0% |
| Verastem, Inc. | Common | 92337C104 | $11.6K | 1,018,827 | 0.0% |
| Illumina, Inc.(ILMN) | Common | 452327109 | $11.5K | 103,841 | 0.0% |
| Pharmacyclics, Inc. | Common | 716933106 | $10.4K | 98,000 | 0.0% |
| Hologic, Inc.(HOLX) | Common | 436440101 | $9.9K | 444,687 | 0.0% |
| McKesson Corporation(MCK) | Common | 58155Q103 | $9.2K | 56,862 | 0.0% |
| Ironwood Pharmaceuticals, Inc.(IRWD) | Common | 46333X108 | $8.9K | 768,050 | 0.0% |
| Forest Laboratories, Inc. | Common | 345838106 | $8.8K | 146,500 | 0.0% |
| Impax Laboratories, Inc. | Common | 45256B101 | $8.7K | 344,683 | 0.0% |
| Endo Health Solutions Inc. | Common | 29264F205 | $8.5K | 126,215 | 0.0% |
| Sagent Pharmaceuticals, Inc. | Common | 786692103 | $8.1K | 319,231 | 0.0% |
| Alkermes plc(ALKS) | Shares | G01767105 | $7.9K | 194,870 | 0.0% |
| Catamaran Corporation | Common | 148887102 | $6.9K | 146,000 | 0.0% |
| UnitedHealth Group, Inc.(UNH) | Common | 91324P102 | $6.2K | 82,436 | 0.0% |
| Idexx Laboratories, Inc.(IDXX) | Common | 45168D104 | $6.0K | 56,265 | 0.0% |
| IntelliPharmaCeutics International, Inc. | Common | 458173101 | $5.2K | 1,404,000 | 0.0% |
| Infinity Pharmaceuticals, Inc.(INFIQ) | Common | 45665G303 | $4.8K | 349,899 | 0.0% |
| Merrimack Pharmaceuticals, Inc. | Common | 590328100 | $4.0K | 757,050 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | Common | 64125C109 | $4.0K | 427,790 | 0.0% |
| CVS Caremark Corporation(CVS) | Common | 126650100 | $3.8K | 53,694 | 0.0% |
| Molina Healthcare, Inc.(MOH) | Common | 60855R100 | $3.6K | 105,000 | 0.0% |
| Auxilium Pharmaceuticals, Inc. | Common | 05334D107 | $3.6K | 173,020 | 0.0% |
| Centene Corporation(CNC) | Common | 15135B101 | $3.5K | 60,000 | 0.0% |
| BioDelivery Sciences International, Inc.(BDSIUSD) | Common | 09060J106 | $3.4K | 581,860 | 0.0% |
| Acorda Therapeutics, Inc. | Common | 00484M106 | $3.3K | 112,881 | 0.0% |
| Clovis Oncology, Inc.(CLVSEUR) | Common | 189464100 | $2.0K | 32,658 | 0.0% |
| MEI Pharma, Inc. | Common | 55279B202 | $2.0K | 243,920 | 0.0% |
| NPS Pharmaceuticals, Inc. | Common | 62936P103 | $1.9K | 62,800 | 0.0% |